Table of Content

1. Introduction


2. Research Methodology

3. Executive Summary


4. Market Dynamics

4.1 Growth Driver
4.2 Challenges


5. China Molecular Diagnostic Market & Test Volume

5.1 China Molecular Diagnostic Market
5.2 China Molecular Diagnostic Test Volume


6. Market Share – China Molecular Diagnostic Share Analysis

6.1 Segments
6.2 Disease
6.3 Oncology Test
6.4 Genetic Test
6.5 Infectious Disease Test


7. Volume Share – China Molecular Diagnostics

7.1 Segments
7.2 Disease
7.3 Oncology Test
7.4 Infectious Disease Test
7.5 Genetic Test


8. Disease – China Molecular Diagnostic Test Volume

8.1 Oncology Test Volume

8.1.1 Breast Cancer Test Volume
8.1.2 Colorectal Cancer Test Volume
8.1.3 Prostate Cancer Test Volume

8.2 Infectious Disease Test Volume

8.2.1 Virology Test Volume
8.2.2 HPV Test Volume

8.3 Genetic Test Volume

8.3.1 Blood Screening Test Volume
8.3.2 HLA Test Volume


9. Disease – China Molecular Diagnostic Market

9.1 Oncology Testing Market

9.1.1 Breast Cancer Testing Market
9.1.2 Colorectal Cancer Testing Market
9.1.3 Prostate Cancer Testing Market

9.2 Infectious Disease Testing Market

9.2.1 Virology Testing Market
9.2.2 HPV Testing Market

9.3 Genetic Testing Market

9.3.1 Blood Screening Market
9.3.2 HLA Testing Market


10. China Healthcare Insurance Schemes

10.1 China Healthcare Insurance Schemes

10.1.1 New Rural Cooperative Medical Scheme (NRCMS)
10.1.2 Urban Employed Basic Medical Insurance (UEBMI)
10.1.3 Urban Resident Basic Medical Insurance (URBMI)
10.1.4 Private Health Insurance


11. Profiles of Private Clinical Labs and Diagnostic Services Companies

11.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.

11.1.1 Company Overview
11.1.2 Products and Services Offered by Di’an

11.2 ADICON Clinical Laboratories (Privately held)

11.2.1 Company Overview
11.2.2 Products and Services Offered by ADICON

11.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.

11.3.1 Company Overview
11.3.2 Products and Services Offered by Kingmed

11.4 Kindstar Global (Privately held)

11.4.1 Company Overview
11.4.2 Products and Services Offered by Kindstar

11.5 BGI–Shenzhen

11.5.1 Company Overview
11.5.2 BGI’s Innovative Approach

11.6 OriGene Technologies

11.6.1 Company Overview
11.6.2 Products and Services Offered by OriGene



List of Figures



Figure 3_1: China – Healthcare Spending (Billion US$), 2011 & 2020
Figure 4_1: China – Molecular Diagnostic Market (Million US$), 2015 – 2019
Figure 4_2: China – Forecast for Molecular Diagnostic Market (Million US$), 2020 – 2026
Figure 4_3: China – Molecular Diagnostic Test Volume (Million), 2015 – 2019
Figure 4_4: China – Forecast for Molecular Diagnostic Test Volume (Million), 2020 – 2026
Figure 5_1: China – Molecular Diagnostic Market Share (Percent), 2015 – 2019
Figure 5_2: China – Forecast for Molecular Diagnostic Market Share (Percent), 2020 – 2026
Figure 5_3: China – Molecular Oncology Test Market Share (Percent), 2015 – 2019
Figure 5_4: China – Forecast for Molecular Oncology Test Market Share (Percent), 2020 – 2026
Figure 6_1: China – Molecular Diagnostic Test Volume Share (Percent), 2015 – 2019
Figure 6_2: China – Forecast for Molecular Diagnostic Test Volume Share (Percent), 2020– 2026
Figure 6_3: China – Molecular Oncology Test Volume Share (Percent), 2015 – 2019
Figure 6_4: China – Forecast for Molecular Oncology Test Volume Share (Percent), 2020 – 2026
Figure 7_1: Rural China – Cancer Screening Sites by Cancer Type (Number), 2013
Figure 7_2: China – Oncology Test Volume (Million), 2015 – 2019
Figure 7_3: China – Forecast for Oncology Test Volume (Million), 2020 – 2026
Figure 7_4: China – Breast Cancer Molecular Test Volume (Million), 2015 – 2019
Figure 7_5: China – Forecast for Breast Cancer Molecular Test Volume (Million), 2020 – 2026
Figure 7_6: China – Colorectal Cancer Test Volume (Million), 2015 – 2019
Figure 7_7: China – Forecast for Colorectal Cancer Test Volume (Million), 2020 – 2026
Figure 7_8: China – Prostate Cancer Test Volume (Million), 2015 – 2019
Figure 7_9: China – Forecast for Prostate Cancer Test Volume (Million), 2020 – 2026
Figure 7_10: China – Infectious Disease Test Volume (Million), 2015 – 2019
Figure 7_11: China – Forecast for Infectious Disease Test Volume (Million), 2020 – 2026
Figure 7_12: China – Virology Test Volume (Million), 2015 – 2019
Figure 7_13: China – Forecast for Virology Test Volume (Million), 2020 – 2026
Figure 7_14: China – HPV Test Volume (Thousand), 2015 – 2019
Figure 7_15: China – Forecast for HPV Test Volume (Thousand), 2020 – 2026
Figure 7_16: China – Genetic Test Volume (Million), 2015 – 2019
Figure 7_17: China – Forecast for Genetic Test Volume (Million), 2020 – 2026
Figure 7_18: China – Blood Screening Test Volume (Million), 2015 – 2019
Figure 7_19: China – Forecast for Blood Screening Test Volume (Million), 2020 – 2026
Figure 7_20: China – HLA Test Volume (Thousand), 2015 – 2019
Figure 7_21: China – Forecast for HLA Test Volume (Thousand), 2020 – 2026
Figure 8_1: China – Oncology Testing Market (Million US$), 2015 – 2019
Figure 8_2: China – Forecast for Oncology Testing Market (Million US$), 2020 – 2026
Figure 8_3: China – Breast Cancer Testing Market (Million US$), 2015 – 2019
Figure 8_4: China – Forecast for Breast Cancer Testing Market (Million US$), 2020 – 2026
Figure 8_5: China – Colorectal Cancer Testing Market (Million US$), 2015 – 2019
Figure 8_6: China – Forecast for Colorectal Cancer Testing Market (Million US$), 2020 – 2026
Figure 8_7: China – Prostate Cancer Testing Market (Million US$), 2015 – 2019
Figure 8_8: China – Forecast for Prostate Cancer Testing Market (Million US$), 2020 – 2026
Figure 8_9: China – Infectious Disease Testing Market (Million US$), 2015 – 2019
Figure 8_10: China – Forecast for Infectious Disease Testing Market (Million US$), 2020 – 2026
Figure 8_11: China – Virology Testing Market (Million US$), 2015 – 2019
Figure 8_12: China – Forecast for Virology Testing Market (Million US$), 2020 – 2026
Figure 8_13: China – HPV Testing Market (Million US$), 2015 – 2019
Figure 8_14: China – Forecast for HPV Testing Market (Million US$), 2020 – 2026
Figure 8_15: China – Genetic Testing Market (Million US$), 2015 – 2019
Figure 8_16: China – Forecast for Genetic Testing Market (Million US$), 2020– 2026
Figure 8_17: China – Blood Screening Market (Million US$), 2015 – 2019
Figure 8_18: China – Forecast for Blood Screening Market (Million US$), 2020 – 2026
Figure 8_19: China – HLA Testing Market (Million US$), 2015 – 2019
Figure 8_20: China – Forecast for HLA Testing Market (Million US$), 2020 – 2026
Figure 10–10_1: Kindstar – Collaboration with Hospitals in China (Number), 2006 – 2012
 

 

List of Tables



Table 3_1: China – Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
Table 3_2: Number of hospital beds for every 1,000 people
Table 5_1: China – Molecular Diagnostic Application Market Share (Percent), 2015 – 2019
Table 5_2: China – Forecast for Molecular Diagnostic Application Market Share (Percent), 2020 – 2026
Table 5_3: China – Molecular Genetic Test Market Share (Percent), 2015 – 2019
Table 5_4: China – Forecast for Molecular Genetic Test Market Share (Percent), 2020 – 2026
Table 5_5: China – Molecular Infectious Disease Test Market Share (Percent), 2015 – 2019
Table 5_6: China – Forecast for Molecular Infectious Disease Test Market Share (Percent), 2020 – 2026
Table 6_1: China – Molecular Diagnostic Test Volume Application Share (Percent), 2015 – 2019
Table 6_2: China – Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2020 – 2026
Table 6_3: China – Molecular Infectious Disease Test Volume Share (Percent), 2015 – 2019
Table 6_4: China – Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2020 – 2026
Table 6_5: China – Molecular Genetic Test Volume Share (Percent), 2015 – 2019
Table 6_6: China – Forecast for Molecular Genetic Test Volume Share (Percent), 2020 – 2026